Literature DB >> 15564985

Determinants of white-coat hypertension.

E Dolan1, A Stanton, N Atkins, E Den Hond, L Thijs, P McCormack, J Staessen, E O'Brien.   

Abstract

BACKGROUND: The prevalence of white-coat hypertension (WCH) is considerable in patients referred with elevated office blood pressure. Failure to recognise this phenomenon can lead to the inappropriate use of antihypertensive medications. We undertook this study to determine the profile of patients with WCH.
METHODS: Baseline clinic and daytime ambulatory blood pressures were available from 5716 patients referred over a 22-year period. Individuals were considered to have WCH if they had an elevated clinic blood pressure measurement greater than 140/90 mmHg and normal daytime mean ambulatory blood pressure. Mean age was 53.6 years and 53.2% were female.
RESULTS: The overall prevalence of white-coat hypertension was 15.4%. A higher prevalence was seen amongst older adults, females, and non-smokers.
CONCLUSION: Multivariate logistic regression analysis confirmed these characteristics as independent predictors of WCH.

Entities:  

Mesh:

Year:  2004        PMID: 15564985     DOI: 10.1097/00126097-200412000-00007

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  18 in total

1.  ABPM Induced Alarm Reaction: A Possible Cause of Overestimation of Daytime Blood Pressure Values Reduced By Treatment with Beta-Blockers.

Authors:  Francesco Salvo; Chiara Lonati; Monica Albano; Paolo Fogliacco; Andrea Riccardo Errani; Cinzia Vallo; Michele Berardi; Vito Meinero; Carlo Lorenzo Muzzulini; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-06-06

Review 2.  Prevalence of white-coat and masked hypertension in national and international registries.

Authors:  Manuel Gorostidi; Ernest Vinyoles; José R Banegas; Alejandro de la Sierra
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

Review 3.  White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

Review 4.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

5.  Can an Emotional Reaction Mimicking White-coat Hypertension Cause Hypertensive Crisis and Cardiac Failure?

Authors:  Francesco Salvo; Francesca Camardella; Cinzia Vallo; Paolo Fogliacco; Andrea Riccardo Errani; Michele Berardi; Monica Albano; Vito Meinero; Carlo Lorenzo Muzzulini; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-01-05

6.  Reliability of Oscillometric Blood Pressure Monitoring in Atrial Fibrillation Patients Admitted for Electric Cardioversion.

Authors:  Monica Maselli; Valter Giantin; Domenico Corrado; Alessandro Franchin; Francesca Attanasio; Valentina Pengo; Alessandra Tramontano; Pietro De Toni; Egle Perissinotto; Enzo Manzato
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-09       Impact factor: 3.738

7.  Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.

Authors:  Michele Adolfo Tedesco; Francesco Natale; Raffaele Calabrò
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

8.  Sex differences in primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji
Journal:  Biol Sex Differ       Date:  2012-03-14       Impact factor: 5.027

9.  Socioeconomic inequalities in the prevalence of nine established cardiovascular risk factors in a southern European population.

Authors:  Luís Alves; Ana Azevedo; Susana Silva; Henrique Barros
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  Feasibility of partnering with emergency medical services to identify people at risk for uncontrolled high blood pressure.

Authors:  Hendrika Meischke; Carol Fahrenbruch; Brooke Ike; Peggy Hannon; Jeffrey R Harris
Journal:  Prev Chronic Dis       Date:  2012-02-02       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.